Aileron Therapeutics' Series E Round

Aileron Therapeutics raised a round of funding on November 18, 2013.

Aileron Therapeutics (NASDAQ: ALRN) is a biopharmaceutical company developing and advancing a class of drugs called Stapled Peptides. The company's Stapled Peptides platform is a breakthrough approach…

Articles about Aileron Therapeutics' Series E Round: